It is worth noting that the inhibition of MT1-MMP activity in triple-negative breast cancer mouse models improved tumor profusion and sensitized the tumor to ionizing radiation or doxorubicin treatments [82,102]. This evidence concerns the gene MMP14 and triple-negative breast carcinoma.